期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER LetPub Score 7.9
50 ratings
Rate
Reputation 8.8 Influence 6.9 Speed 8.8 | ||||||||||||||||||||||||
期刊簡稱 | BBA-REV CANCER | ||||||||||||||||||||||||
ISSN | 0304-419X | ||||||||||||||||||||||||
E-ISSN | 1879-2561 | ||||||||||||||||||||||||
h-index | 129 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 1.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/bba-reviews-on-cancer/ | ||||||||||||||||||||||||
在線稿件提交 | http://ees.elsevier.com/bbacan/default.asp?acw=ff33 | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 161每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 17.86% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0304-419X%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) 來自Elsevier的數據: Average 4.9 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 5.8 Week(s) | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER] 的評論 | 撰寫評論 |
作者: 袁 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-01-08 21:56:00 評論於 I am so grateful to the journal's managing editor Marina Holz for her fast and careful review. I submitted my first review article on September 25, 2024, to my first journal, with a mindset of just giving it a try. Three days later, I received a reply, and to my surprise, the editor didn't reject it outright, but instead asked me to make some revisions (including deleting some sections and adding a few relevant references) before helping me with the submission, with a deadline of two months. I added a lot of content afterwards, carefully revised the article, and created some beautiful illustrations. On November 9, I resubmitted, and after a minor revision on December 20, it went to two reviewers who pointed out some minor issues. I made the revisions on December 27, thinking that the publishing house would be closed for Christmas and New Year. However, they were actually working overtime! It was accepted on December 28 and published online on December 30, just in time for the new year. It's worth mentioning that this journal first publishes online, then proofreads, and finally replaces the online version with the proofread one very quickly. Additionally, this is a hybrid journal that allows both open access and subscription. I initially chose open access, but after acceptance, I switched to subscription, which was also possible. Thanks to BBA reviews on cancer, and thanks to Dr. Holz. ![]() ![]() |
作者: xxxx---- 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-11-21 08:33:42 評論於 Submission on September 20, 2024 Revision on October 8, 2024, with a deadline of one month. The comments from two reviewers were very insightful, so I made some significant revisions. Revised on November 18, 2024, and sent to reviewers the next day. Accepted on November 21, 2024. ![]() ![]() |
作者: 虎鹤修雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-05 11:12:45 評論於 Review speed: 3.0 | Submission hit rate: 50.0 Emphasized research direction: tumor Experience sharing: After submission, it took about 3 weeks for the review process. You can track the progress of the review through the track website provided by Elsevier in the email. Once you have received opinions from 2 reviewers, you can proceed. My first review took 3 months and required major revisions. The comments provided were fair and friendly, and I was able to complete the revisions and resubmit within two weeks. On the 3rd day after submitting the revised manuscript, the editor sent it for a second review. Within 1 day, one reviewer accepted the invitation for the second review, and within 3 days, this reviewer submitted their comments. After a week, the second reviewer had not accepted the invitation yet, but the editor proceeded with the review and accepted the feedback. The entire second review process only took a week, and I am grateful that the editor did not seek additional reviewers. In conclusion, both the editor and the reviewers were responsible and efficient. As a side note, one reviewer in the first review provided feedback within a day, which initially caused concern about a possible rejection due to the speed. However, both reviewers' comments were fair and friendly. I share this submission experience for reference and wish everyone smooth submissions. ![]() ![]() |
作者: Grover 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-19 13:42:48 評論於 Still under external audit. ![]() ![]() |
作者: 玉鑫酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-11 21:24:43 評論於 Pick up and drop off for review. ![]() ![]() |
作者: 玉鑫酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-11 20:40:04 評論於 It has been the same week. ![]() ![]() |
作者: Bing Doyle 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-11 13:34:34 評論於 Hello, how have you been recently? ![]() ![]() |
作者: Bing Doyle 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-11 10:09:48 評論於 Hello, how is the progress of your subsequent review going? ![]() ![]() |
作者: Grover 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-03 21:27:55 評論於 May I ask if the review process is fast? It's been the first week since I submitted it to the editor. ![]() ![]() |
作者: 北风文彦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-03 20:00:55 評論於 It was submitted for review about three weeks ago. ![]() ![]() |
作者: 珉林辛亥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-22 15:56:30 評論於 How long will it take for you to reply? ![]() ![]() |
作者: 葵花雨珍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-17 14:06:49 評論於 How about a few days for a change? ![]() ![]() |
作者: dcshyc 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-09 08:01:47 評論於 Is there any result for me as well? It's been over half a month, has the status not changed after the external review? ![]() ![]() |
作者: dcshyc 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-09 07:59:44 評論於 It has been more than half a month since I submitted the manuscript to the editor ![]() ![]() |
作者: 北风文彦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-14 19:08:22 評論於 Hello, may I ask if there have been any developments lately? I have been with editor for 15 days ![]() ![]() |
作者: 润发大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-10 18:14:51 評論於 Review Speed: 12.0 | Acceptance Rate: 50.0 Experience Sharing: After submitting for a year, I finally got accepted without any publication fee. They immediately edited the paper and it was online the same day. A great New Year's gift ![]() ![]() |
作者: 中原向雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-29 23:51:25 評論於 Focused research direction: Tumor experience sharing: with editor It's been 15 days, is it so slow? ![]() ![]() |
作者: 北风笑萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-28 12:34:24 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 50.0 Experience Sharing: 1 ![]() ![]() |
作者: 龟甲林楠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-13 22:26:35 評論於 ![]() ![]() |
作者: 龟甲林楠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-13 19:21:33 評論於 There is no text to translate ![]() ![]() |
作者: 龟甲林楠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-13 09:32:28 評論於 I don't know ![]() ![]() |
作者: 羽彤mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-08 09:46:31 評論於 How to contact the editor-in-chief? ![]() ![]() |
作者: 子薇姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-19 13:16:26 評論於 Review speed: 2.0 | Submission acceptance rate: 25.0 Emphasized research directions: Tumor; Tumor treatment; Tumor markers Experience sharing: Sent an abstract to the editor-in-chief first, and started writing the paper after his approval. Got feedback in less than 2 months, the reviewers were very serious and provided a lot of comments. After major revisions, the paper was submitted again, and after minor revisions about a month later, it was accepted. The entire process took less than three months. No charges ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:05:30 評論於 According to the format requirements of the corresponding journal, write accordingly. If there is no fixed format, you can choose a suitable format depending on the type of article. Regardless of the format, structuring the abstract makes the data information clearer and more understandable ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:35:50 評論於 Different types: Descriptive, Informational, and Structured. Descriptive abstracts are typically used in social sciences and humanities, providing general information about the research without specific details on methods and conclusions. Informational abstracts are commonly found in scientific papers, presenting details about the research background, objectives, methods, results, and conclusions. Structured abstracts are information-focused, composed of a series of headings (e.g. research objectives, methods, results, conclusions), mainly used in medical papers and clinical trial reports ![]() ![]() |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us